◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

ROCK CREEK PHARMACEUTICALS, INC.

CIK: 776008 SIC: 2833
-
Revenue
$-11.15M
Net Income
-
Gross Margin
-
Op. Margin
-
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 6 of 16 quarterly reports available
Breakdown Q2 2016
(Jun 30, 2016)
Q1 2016
(Mar 31, 2016)
Q4 2015
(Dec 31, 2015)
Q3 2015
(Sep 30, 2015)
Q2 2015
(Jun 30, 2015)
Q1 2015
(Mar 31, 2015)
Operating Expenses $2.02M $1.36M $1.98M $3.50M $2.02M $3.82M
Research & Development $113.00K $133.00K $369.00K $1.27M $376.00K $473.00K
Operating Income $-2.02M $-1.36M $-1.98M $-3.50M $-2.02M $-3.82M
Interest Expense $793.00K $1.34M $386.00K $24.00K $17.00K $11.00K
Other Income/Expense $21.00K $11.00K $-195.00K $287.00K $-13.00K $3.52M
Income Before Tax - - $-2.82M $-2.83M $-813.00K $-297.00K
Income Tax Expense - - - - - -
Net Income $-2.79M $-2.69M $-2.82M $-2.84M $-843.00K $-338.00K
Breakdown Q2 2016
(Jun 30, 2016)
Q1 2016
(Mar 31, 2016)
Q4 2015
(Dec 31, 2015)
Q3 2015
(Sep 30, 2015)
Q2 2015
(Jun 30, 2015)
Q1 2015
(Mar 31, 2015)
Cash & Cash Equivalents $185.00K $552.00K $493.00K $146.00K $2.99M $91.00K
Other Current Assets $9.00K $549.00K $485.00K $847.00K $96.00K $719.00K
Total Current Assets $194.00K $1.10M $1.04M $996.00K $3.09M $4.34M
Property Plant & Equipment $147.00K $159.00K $170.00K $181.00K $192.00K $204.00K
Intangible Assets $50.00K $52.00K $55.00K $350.00K $367.00K $385.00K
Total Assets $11.78M $13.98M $19.55M $2.03M $4.16M $5.44M
Accrued Liabilities $4.19M $3.38M $3.88M $4.25M $6.30M $9.51M
Total Current Liabilities $22.02M $21.83M $22.19M $11.18M $10.51M $14.45M
Long-term Debt $2.74M $4.17M $8.00M $350.00K $350.00K $350.00K
Total Liabilities $24.77M $26.00M $30.19M $11.53M $10.86M $14.80M
Common Stock $15.00K $2.00K $1.00K $1.00K $1.00K $1.00K
Retained Earnings $-315.42M $-312.63M $-309.94M $-307.11M $-304.27M $-303.33M
Total Stockholders Equity $-12.99M $-12.03M $-10.65M $-9.50M $-6.70M $-9.36M
Total Liabilities & Equity $11.78M $13.98M $19.55M $2.03M $4.16M $5.44M
Breakdown Q2 2016
(Jun 30, 2016)
Q1 2016
(Mar 31, 2016)
Q4 2015
(Dec 31, 2015)
Q3 2015
(Sep 30, 2015)
Q2 2015
(Jun 30, 2015)
Q1 2015
(Mar 31, 2015)
Net Income $-5.49M $-2.69M $-2.82M $-2.84M $-843.00K $-338.00K
Depreciation & Amortization $28.00K $14.00K $60.00K $86.00K $58.00K $29.00K
Stock-based Compensation $67.00K $33.00K $77.00K $883.00K $539.00K $659.00K
Operating Cash Flow - - - - - $-1.68M
Capital Expenditure - - - $8.00K $8.00K $8.00K
Investing Cash Flow - - - - - $-8.00K
Debt Repayment $3.00M $3.00M - - - -
Stock Issued - - - $4.64M $4.64M $879.00K
Financing Cash Flow - - - - - $1.38M
Net Change in Cash $-308.00K $59.00K $347.00K $-249.00K $2.60M $-304.00K
SEC Filing Format - Data shown as it appears in the Q2 2016 (10-Q) filing Period ended: Jun 30, 2016
Condensed Consolidated Statements of Operations
Description Jun 30, 2016 Jun 30, 2016
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $2.02M $2.02M $3.38M $5.84M
Research & Development $113.00K $376.00K $245.00K $850.00K
Operating Income $-2.02M $-2.02M $-3.38M $-5.84M
Interest Expense $793.00K - $2.13M -
Other Income/Expense $21.00K $-13.00K $32.00K $3.51M
Net Income $-2.79M $-843.00K $-5.49M $-1.18M
Condensed Consolidated Balance Sheets
Description Jun 30, 2016 Dec 31, 2015
Cash & Cash Equivalents $185.00K $493.00K
Other Current Assets $9.00K $485.00K
Total Current Assets $194.00K $1.04M
Property Plant & Equipment $147.00K $170.00K
Intangible Assets $50.00K $55.00K
Total Assets $11.78M $19.07M
Accrued Liabilities $4.19M $3.88M
Total Current Liabilities $22.02M $22.19M
Long-term Debt $2.74M $7.52M
Total Liabilities $24.77M $29.71M
Common Stock $15.00K $1.00K
Retained Earnings $-315.42M $-309.94M
Total Stockholders Equity $-12.99M $-10.65M
Total Liabilities & Equity $11.78M $19.07M
Condensed Consolidated Statements of Cash Flows
Description Jun 30, 2016 Jun 30, 2016
Current Prior Year Current YTD Prior Year YTD
Net Income $-2.79M $-843.00K $-5.49M $-1.18M
Depreciation & Amortization - - $28.00K $58.00K
Stock-based Compensation - - $67.00K $539.00K
Capital Expenditure - - - $8.00K
Debt Repayment - - $3.00M -
Net Change in Cash - - $-308.00K $2.60M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...